521 related articles for article (PubMed ID: 23103614)
1. Blocking the natural killer cell inhibitory receptor NKG2A increases activity of human natural killer cells and clears hepatitis B virus infection in mice.
Li F; Wei H; Wei H; Gao Y; Xu L; Yin W; Sun R; Tian Z
Gastroenterology; 2013 Feb; 144(2):392-401. PubMed ID: 23103614
[TBL] [Abstract][Full Text] [Related]
2. Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir.
Stelma F; de Niet A; Tempelmans Plat-Sinnige MJ; Jansen L; Takkenberg RB; Reesink HW; Kootstra NA; van Leeuwen EM
J Infect Dis; 2015 Oct; 212(7):1042-51. PubMed ID: 25791117
[TBL] [Abstract][Full Text] [Related]
3. Frequency and role of NKp46 and NKG2A in hepatitis B virus infection.
Yoshioka T; Tatsumi T; Miyagi T; Mukai K; Nishio K; Nishio A; Yokoyama Y; Suda T; Kegasawa T; Shigekawa M; Hikita H; Sakamori R; Takehara T
PLoS One; 2017; 12(3):e0174103. PubMed ID: 28328926
[TBL] [Abstract][Full Text] [Related]
4. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication.
Wang XX; Pan XB; Han JC; Cong X; Jin Q; Kong XS; Wei L; Feng B
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):233-240. PubMed ID: 29625837
[TBL] [Abstract][Full Text] [Related]
5. Natural Killer Group 2A Expressed on Both Peripheral CD3
Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
[TBL] [Abstract][Full Text] [Related]
6. Antiviral treatment alters the frequency of activating and inhibitory receptor-expressing natural killer cells in chronic hepatitis B virus infected patients.
Lv J; Jin Q; Sun H; Chi X; Hu X; Yan H; Pan Y; Xiao W; Tian Z; Hou J; Xu D; Tu Z; Niu J
Mediators Inflamm; 2012; 2012():804043. PubMed ID: 23304062
[TBL] [Abstract][Full Text] [Related]
7. Functional restoration of CD56
Chen T; Zhu L; Shi A; Ding L; Zhang X; Tan Z; Guo W; Yan W; Han M; Jia J; Luo X; Schuppan D; Ning Q
Hepatol Int; 2017 Sep; 11(5):419-428. PubMed ID: 28639033
[TBL] [Abstract][Full Text] [Related]
8. Effects of entecavir on peripheral blood lymphocyte profiles in chronic hepatitis B patients with suboptimal responses to adefovir.
Zhang L; Wang Q; Zhao P; Hu X; Jiang Y
Clin Exp Pharmacol Physiol; 2014 Jul; 41(7):514-23. PubMed ID: 24773272
[TBL] [
